Article
Tumor subtype defines distinct pathways of molecular and clinical progression in primary prostate cancer
16 May 2021
Abstract excerpt
BACKGROUNDMolecular characterization of prostate cancer (PCa) has revealed distinct subclasses based on underlying genomic alterations occurring early in the natural history of the disease. However, how these early alterations influence subsequent molecular events and the course of the disease over its long natural history remains unclear.METHODSWe explored the molecular and clinical progression of different...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
